You searched for ustr - Page 117 of 151 - Knowledge Ecology International

2011: The Year Ahead at WHO, WIPO and WTO

Posted on January 5, 2011 by Thiru

As 2011 unfolds, the following conferences and negotiations are expected to shape the knowledge governance landscape this year at WHO, WIPO and WTO.

World Health Organization

Continue Reading →

Uncategorized

Differences in deaths for 6 cancer types in 14 WHO regions, with reference to income of region

A pdf version of this document is available here.

KEI Research Note 2010:5
December 23, 2010

Differences in ratio of deaths to new cases for 6 cancer types in 14 WHO regions, with reference to income of region

Introduction

Continue Reading →

Ratio of year 2000 breast cancer deaths to new breast cancer patients in Europe, by country and country income

Posted on December 21, 2010 by James Love

The following graph presents the year 2000 raw mortality rate of breast cancer patients in 36 European Countries. The graph compares the ratio of breast cancer deaths to the annual incidence of breast cancer, to the per capita incomes in those countries, all based upon year 2000 data. Continue Reading →

NIH funded research involving trastuzumab (marketed by Roche under the trade name Herceptin)

Posted on December 10, 2010 by James Love

13 December 2010

Drugs@FDA
Drug Name(s) HERCEPTIN (Brand Name Drug)
FDA Application No. (BLA) 103792
Active Ingredient(s) TRASTUZUMAB
Company GENENTECH (Roche acquired a majority ownership in 1990, and full ownership in March 2009.)
Original Approval or Tentative Approval Date September 25, 1998

What is Herceptin? How does it work?

Continue Reading →

Statements by KEI and others on NIH rejection of Fabrazyme March-In Request

Posted on December 7, 2010 by James Love

For background on the Fabrazyme case, see: https://www.keionline.org/fabrazyme

The following statements were made today by civil society on the NIH rejection of the Fabrazyme March-in Request Petition. Contact Judit Rius at judit.rius@keionline.org if your organization would like to submit an statement.

Statement by James Love, Director of Knowledge Ecology International (KEI) (Contact: 1.202.361.3040)

Continue Reading →

Microsoft, Gates Foundation Timeline

November 29, 2010 Revised January 4, 2011 Introduction This timeline contains a number of selected data points concerning Microsoft and the Bill and Melinda Gates Foundation (BMGF). The motivations for this timeline, which features entries for both Microsoft and the… Continue Reading →

KEI statement to Committee on Development and Intellectual Property on WIPO project on IP and Competition Policy

Posted on November 24, 2010 by Thiru

Knowledge Ecology International made the following intervention today at the 6th Session of the WIPO Committee on Development and Intellectual Property (CDIP).

KEI statement to WIPO CDIP 6 on Agenda item 5

Thank you Ambassador and congratulations on your appointment as Chair of this Committee.

Continue Reading →

Uncategorized

Revealing study by L Yager (GAO): ‘Observations on efforts to quantify the economic effects of counterfeit and pirated goods’

Posted on November 24, 2010 by Thiru

The 6th session of the WIPO Advisory Committee on Enforcement is taking place in Geneva from 1-2 December 2010. KEI’s observations on the 5th session, entitled, Positive outcome reached at WIPO Advisory Committee on Enforcement while ACTA looms in the East can be found here:/node/681.

Continue Reading →

Non-responsive letter from David Kappos of USPTO to Senators Sanders and Brown regarding ACTA consistency with US law

Posted on November 18, 2010 by James Love

In a October 19, 2010, Senators Bernard Sanders (I-VT) and Sherrod Brown (D-OH) wrote to David Kappos, the Director of the USPTO, asking for an assessment of conflicts between the October 2010 ACTA text, and U.S. law. (attached here).

Undersecretary of Commerce for
Intellectual Property, David Kappos

Continue Reading →

A KEI note to Library of Congress about ACTA text

Posted on November 16, 2010 by James Love

From: James Love
To: Michele Woods
Cc: Nancy Weiss
Subject: Some examples of US inconsistency with ACTA
Date: Fri, 12 Nov 2010 07:29:09 -0500

This note cites several areas where US law is plainly inconsistent with
ACTA.

In addition, in a separate analysis,I have called attention to proposed
legislation in USA on orphan copyrighted works that are very
inconsistent with ACTA provisions on remedies.
https://www.keionline.org/node/980

Some examples of inconsistencies between ACTA and US law

Continue Reading →

Uncategorized

Search Results for: ustr

2011: The Year Ahead at WHO, WIPO and WTO

Differences in deaths for 6 cancer types in 14 WHO regions, with reference to income of region

Differences in ratio of deaths to new cases for 6 cancer types in 14 WHO regions, with reference to income of region

Introduction

Ratio of year 2000 breast cancer deaths to new breast cancer patients in Europe, by country and country income

NIH funded research involving trastuzumab (marketed by Roche under the trade name Herceptin)

What is Herceptin? How does it work?

Statements by KEI and others on NIH rejection of Fabrazyme March-In Request

Microsoft, Gates Foundation Timeline

KEI statement to Committee on Development and Intellectual Property on WIPO project on IP and Competition Policy

Revealing study by L Yager (GAO): ‘Observations on efforts to quantify the economic effects of counterfeit and pirated goods’

Non-responsive letter from David Kappos of USPTO to Senators Sanders and Brown regarding ACTA consistency with US law

A KEI note to Library of Congress about ACTA text

Categories